Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b
Ropeginterferon alfa-2b (Ropeg) is approved for the treatment of adults with polycythemia vera (PV). This report aims to analyze the ethnic sensitivity of Ropeg for the treatment of PV, comparing the pharmacokinetics (PK), efficacy, and safety profiles across diverse ethnic groups. We conducted a re...
Saved in:
Main Authors: | Albert Qin (Author), Daoxiang Wu (Author), Jason Liao (Author), Shuping Xie (Author), Haoqi Chen (Author), Yucheng Gao (Author), Jie Cui (Author), Xia Su (Author), Narihisa Miyachi (Author), Toshiaki Sato (Author), Yaning Li (Author), Jingjing Zhang (Author), Weihong Shen (Author), Wei Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera
by: Aaron T Gerds, et al.
Published: (2023) -
Bilateral adrenal hemorrhage in polycythemia vera
by: Shruti Bhandari, et al.
Published: (2016) -
Persistent neutrophilia progressing to polycythemia vera
by: Smita Singh, et al.
Published: (2011) -
Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese Subjects
by: Min Zhu, et al.
Published: (2021) -
Aquagenic Pruritus in Polycythemia Vera: Clinical Characteristics
by: Edyta Lelonek, et al.
Published: (2018)